China Pharmaceutical Chain Industry Report, 2010
  • Dec/2010
  • Hard Copy
  • USD $1,300
  • Pages:55
  • Single User License
    (PDF Unprintable)       
  • USD $1,200
  • Code: YF009
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $1,800
  • Hard Copy + Single User License
  • USD $1,500
Recent years have seen rapid growth of China’s pharmaceutical retail market, with expanding scale of chain enterprises and increasing number of drugstores, thanks to a fast-growing pharmaceutical industry and an aging population in China. In 2009, China’s pharmaceutical retail market scale reached RMB 153.1 billion, up 18.2% year-on-year. In particular, China’s top 100 pharmaceutical chain enterprises reaped RMB 58.1 billion in total, accounting for 37.9% of the total sales of the pharmaceutical retail industry. By the end of 2009, China had 2,099 pharmaceutical chain enterprises and 160,000 chain drugstores, up 5.7% and 24.0% year-on-year respectively.

Sales and YoY Growth Rate of China’s Top 100 Pharmaceutical Chain Enterprises, 2003-2009 (RMB bn, %)
Source: ResearchInChina

This report not only highlights both the overall development and regional development of China’s pharmaceutical chain industry, but also elaborates on the operation of 14 pharmaceutical chain enterprises including Nepstar Drugstore, LBX Pharmacy, Guangdong Da Shen Lin and Hubei Ready Medicine Industry.

A case in point is Nepstar Drugstore, whose single-store profit decreased by 14.6% year on year to RMB 45,000 in 2009. Compared with the single-store profit of RMB 52,000 and year-on-year decline of 42.2% in 2008, the single-store profit in 2009 showed a downward trend, but at a slower rate, which can be attributable to three aspects: firstly, the proportion of self-owned brand drugs with higher gross profit margin has been increasing; secondly, the cost has been lowered through centralized procurement; thirdly, the profitability has been improved through increasing the sales revenue from non-drug products like nourishments.

Operating Profit and Single-store Profitability of Nepstar Drugstore, 2006-2009
Source: Annual Report of Nepstar Drugstore; ResearchInChina

1. Overview
1.1 Pharmaceutical Industry Chain
1.2 Development Features of China Pharmaceutical Chain Industry
1.2.1 Low Concentration
1.2.2 Slender Differentiation 
1.2.3 Difficult Diversified Operation

2. Operating Environment 
2.1 Economic Environment
2.2 Policy Environment

3. Development
3.1 Global Pharmaceutical Retail Market
3.2 Pharmaceutical Retail Market in China
3.3 Chain Drugstores in China

4. Development in Key Regions
4.1 East China
4.2 North China
4.3 Central China
4.4 South China
4.5 Northeast China
4.6 Northwest China
4.7 Southwest China

5. Key Pharmaceutical Chain Enterprises 
5.1 Nepstar Drugstore
5.1.1 Profile 
5.1.2 Operation
5.1.3 Strategy 
5.2 LBX Pharmacy
5.2.1 Profile
5.2.2 Operation
5.3 Guangdong Da Shen Lin
5.3.1 Profile
5.3.2 Operation
5.4 Hubei Ready Medicine Industry
5.4.1 Profile
5.4.2 Operation
5.5 Chongqing Tongjunge Pharmacy
5.5.1 Profile
5.5.2 Operation
5.6 Guoda Pharmacy
5.6.1 Profile
5.6.2 Operation
5.7 Yunnan Hongxiang Yixintang Pharmacy
5.7.1 Profile
5.7.2 Operation
5.8 Liaoning Chengda Fangyuan Pharmaceutical Chain
5.8.1 Profile
5.8.2 Operation
5.9 Guangdong Bencao Medicine Co., Ltd.
5.9.1 Profile
5.9.2 Operation
5.10 Chongqing Peace Drugstore
5.10.1 Profile
5.10.2 Operation
5.11 Shanghai Huashi Pharmacy Co. Ltd.
5.11.1 Profile
5.11.2 Operation
5.12 Tongrentang (TRT)
5.12.1 Profile
5.12.2 Operation
5.13 Beijing Golden Elephant Pharmacy
5.13.1 Profile
5.13.2 Operation
5.14 Cachet Pharmaceutical Stock Corporation Ltd (Cachet)
5.14.1 Profile
5.14.2 Operation
China’s Pharmaceutical Industry Chain
Total Health Spending and Its Proportion in GDP of China, 2005-2009
Constitution of Total Health Spending in China, 2005-2008
Population Ages 65 and Above and Its Proportion in China, 2003-2009
Related Policies of Pharmaceutical Chain Industry in China
Sales and YoY Growth Rate of Global Pharmaceutical Market, 2002-2009
Sales and Growth Rate of Drugs Worldwide by Region, 2009
Market Scale and YoY Growth Rate of Drug Terminal Market in China, 2003-2009
Market Scale and YoY Growth Rate of Drug Retail Market in China, 2003-2009
Proportion of Large-scale Retail Terminals in Chinese Pharmaceutical market, 2003-2009
Growth Rate of Sales of Retail Drugstores in Rural and Urban Regions, 2005-2009
Number of Chain Drugstores and Single Drugstores in China, 2003-2009
Number and YoY Growth Rate of China-based Drug Retail Chain Enterprises, 2006-2009
Sales and YoY Growth Rate of Top 100 Drugstores, 2003-2009
Sales and Proportion of Top 100 Pharmaceutical Chain Enterprises by Region, 2009 
Sales and Number of Outlets of Top 10 Pharmaceutical Chain Enterprises, 2009
Sales of Top 10 Pharmaceutical Chain Enterprises in Eastern China and Ranking of Pharmaceutical Chain Enterprises in China, 2009
Top 10 Pharmaceutical Chain Enterprises in North China and Sales, 2009
Number of Regular Chain Stores and Franchised Outlets of Beijing-based Top 4 Chain Drugstores, as of August 2010
Enterprises and Sales of Top 100 Pharmaceutical Chain Enterprises in Central China, 2009
Enterprises and Sales of Top 10 Pharmaceutical Chain Enterprises in South China, 2009
Enterprises and Sales of Top 10 Pharmaceutical Chain Enterprises in Northeast China, 2009
Enterprises and Sales of Top 6 Pharmaceutical Chain Enterprises in Northwest China, 2009
Sales of Top 100 Pharmaceutical Chain Enterprises in Southwest China, 2009 
Operating Income and Net Profit of Nepstar Drugstore, 2007-2009
Net Profit Margin and Gross Profit Margin of Nepstar Drugstore, 2004-2009
Operating Income of Nepstar Drugstore by Product, 2007-2009
Number of Chain Drugstores of Nepstar Drugstore, 2005-2009
Number of Chain Drugstores of Nepstar Drugstore by Region, 2007-2009
Sales and YoY Growth Rate of LBX Pharmacy, 2003-2009
Number of Chain Drugstores and YoY Growth Rate of LBX Pharmacy, 2007-2009
Sales and YoY Growth Rate of Guangdong Da Shen Lin, 2007-2009
Number of Chain Drugstores and YoY Growth Rate of Guangdong Da Shen Lin, 2003-2009
Sales and YoY Growth Rate of Hubei Ready Medicine Industry, 2005-2009
Number of Regular Chain Stores and Franchised Outlets of Hubei Ready Medicine Industry, 2003-2009
Operating Income and Net Profit of Chongqing Tongjunge Pharmacy, 2007-2010 H1
Number of Regular Chain Stores and Franchised Outlets of Chongqing Tongjunge Pharmacy, 2003-2009
Sales and YoY Growth Rate of Guoda Pharmacy, 2006-2009
Number of Regular Chain Stores and Franchised Outlets of Guoda Pharmacy, 2007-2009
Sales and YoY Growth Rate of Yunnan Hongxiang Yixintang Pharmacy, 2005-2009
Number of Regular Chain Stores and Franchised Outlets of Yunnan Hongxiang Yixintang Pharmacy, 2003-2009
Distribution of Chain Drugstores of Yunnan Hongxiang Yixintang Pharmacy, October 2010 
Sales and YoY Growth Rate of Liaoning Chengda Fangyuan Pharmaceutical Co., Ltd., 2003-2009 
Number of Regular Chain Stores and Franchised Outlets of Liaoning Chengda Fangyuan Pharmaceutical Co., Ltd., 2005-2009
Sales and YoY Growth Rate of Guangdong Bencao Medicine Co., Ltd., 2005-2009 
Number of Regular Chain Stores and Franchised Outlets of Guangdong Bencao Medicine Co., Ltd., 2005-2008
Sales and YoY Growth Rate of Chongqing Peace Drugstore, 2005-2009   
Number of Regular Chain Stores and Franchised Outlets of Chongqing Peace Drugstore, 2005-2009
Sales and YoY Growth Rate of Shanghai Huashi Pharmacy, 2005-2009
Number of Regular Chain Stores and Franchised Outlets of Shanghai Huashi Pharmacy, 2005-2009
Sales and Net Profit of Tongrentang (TRT), 2006-2010 H1
Export Value of Tongrentang (TRT), 2001-2009
Sales Revenue and YoY Growth Rate of Beijing Golden Elephant Pharmacy, 2005-2009
Number of Regular Chain Stores and Franchised Outlets of Beijing Golden Elephant Pharmacy, 2004-2008
Retail Drug Revenue and YoY Growth Rate of Cachet, 2006-2009
Gross Profit Margin of Cachet by Business, 2007-2009

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Monoclonal Antibody Industry Report, 2013-2017

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the m...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Independent Clinical Laboratory Industry Report,2013-2015

Restricted by the health care system and the medical inspection level (Chinese firms mainly lag behind foreign counterparts in molecular diagnostics and other special tests), Chinese independent clini...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Chemical Pharmaceutical Industry Report, 2011

In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...

China Pharmaceutical Equipment Industry Report, 2011-2012

In recent years, Chinese pharmaceutical equipment industry has witnessed significant growth in both product quality and technological content, as well as steady rise of sales volume. According to Chin...

China Animal Vaccine Industry Report, 2010-2011

China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the in...

China Human Vaccine Industry Report, 2010-2011

With the improvement of economy and people’s disease prevention awareness, China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号